Halozyme Therapeutics, Inc.

BLAIR WILLIAM & CO/IL HALO

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/8/2026

Shares

10,203

Value ($000)

659

Weight

0.0%

2013 Q4 - 2026 Q1 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/8/2026	659	0.0%	10,203	3/31/2026
2024 Q3	11/12/2024	237	0.0%	4,149	9/30/2024
2024 Q2	8/12/2024	16	0.0%	312	6/30/2024
2022 Q4	2/10/2023	854	0.0%	15,017	12/31/2022
2022 Q3	11/9/2022	671	0.0%	16,977	9/30/2022
2022 Q2	8/10/2022	751	0.0%	17,073	6/30/2022
2022 Q1	5/13/2022	802	0.0%	20,098	3/31/2022
2021 Q4	2/14/2022	814	0.0%	20,251	12/31/2021
2021 Q3	11/12/2021	822	0.0%	20,217	9/30/2021
2021 Q2	8/12/2021	883	0.0%	19,452	6/30/2021
2021 Q1	5/13/2021	884	0.0%	21,203	3/31/2021
2020 Q4	2/9/2021	1,035	0.0%	24,228	12/31/2020
2020 Q3	11/6/2020	703	0.0%	26,750	9/30/2020
2020 Q2	8/12/2020	747	0.0%	27,866	6/30/2020
2020 Q1	5/11/2020	475	0.0%	26,413	3/31/2020
2019 Q4	2/13/2020	380	0.0%	21,443	12/31/2019
2014 Q2	8/1/2014	681	0.0%	69,001	6/30/2014
2014 Q1	5/6/2014	876	0.0%	69,001	3/31/2014
2013 Q4	2/11/2014	1,026	0.0%	68,501	12/31/2013